Evidence map›Paper›PMID 27406819›Full record

ArticleEMBO molecular medicine2016

Prolonged contact with dendritic cells turns lymph node-resident NK cells into anti-tumor effectors.

Francesca Mingozzi, Roberto Spreafico, Tatiana Gorletta, Clara Cigni, Marco Di Gioia, Michele Caccia, Laura Sironi, Maddalena Collini, Matias Soncini, Michela Rusconi and 4 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in EMBO molecular medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04789252 (Heterogeneity of Dendritic Cells and Other Cells of Myeloid and Lymphoid Origin in Colon and Non-small Cell Lung Cancer), which is not on this map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04789252 unknown statusnot on this mapstarted 2021, after this paper: background citation

Heterogeneity of Dendritic Cells and Other Cells of Myeloid and Lymphoid Origin in Colon and Non-small Cell Lung Cancer

TypeobservationalSponsorUniversity of Milano BicoccaRan2021 to 2026Enrolled64ConditionsNon-small Cell Lung CancerArmsBioinformatics analysis of single cell transcriptomics data
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 33 citations in OpenAlex.

  1. APL bioengineering · 2024
    Article
  2. Bioinformatic Analysis of the CXCR2 Ligands in Cancer Processes.International journal of molecular sciences · 2023
    Article
  3. NK Cells in Cancer: Mechanisms of Dysfunction and Therapeutic Potential.International journal of molecular sciences · 2023
    Review
  4. Development and function of chicken XCR1Frontiers in immunology · 2023
    Article
  5. Article
  6. Determination of Pleiotropic Effect of Warfarin inFrontiers in cardiovascular medicine · 2022
    Article
  7. Review
  8. Article
  9. Review
  10. Dendritic cell biology and its role in tumor immunotherapy.Journal of hematology & oncology · 2020
    Review
  11. Review
  12. Review
  13. Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1.Journal of immunology (Baltimore, Md. : 1950) · 2018
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Frontiers in immunology · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Francesca MingozziDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy.
Roberto SpreaficoDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy.
Tatiana GorlettaDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy.
Clara CigniDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy.
Marco Di GioiaHarvard Medical School and Division of Gastroenterology, Boston Children's Hospital, Boston, MA, USA.
Michele CacciaDepartment of Physics, University of Milano-Bicocca, Milan, Italy.
Laura SironiDepartment of Physics, University of Milano-Bicocca, Milan, Italy.
Maddalena ColliniDepartment of Physics, University of Milano-Bicocca, Milan, Italy.
Matias SonciniHumanitas Clinical and Research Center, Rozzano (MI), Italy.
Michela RusconiDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy.
Ulrich H von AndrianDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, USA The Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.
Giuseppe ChiricoDepartment of Physics, University of Milano-Bicocca, Milan, Italy.
Ivan ZanoniDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy Harvard Medical School and Division of Gastroenterology, Boston Children's Hospital, Boston, MA, USA Humanitas Clinical and Research Center, Rozzano (MI), Italy ivan.zanoni@childrens.harvard.edu francesca.granucci@unimib.it.
Francesca GranucciDepartment of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy Humanitas Clinical and Research Center, Rozzano (MI), Italy ivan.zanoni@childrens.harvard.edu francesca.granucci@unimib.it.ORCID 0000-0002-7046-4914
University of Milano-Bicocca · ITBoston Children's Hospital · USHumanitas University · ITHarvard University · US

Funding

STRUCTURE-FUNCTION RELATIONSHIPS IN THE ALIMENTARY TRACTP30DK034854 · NIDDK · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI Susan J Hagen · 1986 to 2026
$32.4M
P3: Chemokine-Mediated T Cell Trafficking in HIV Transmission and Immune ResponseP01AI112521 · NIAID · HARVARD MEDICAL SCHOOL · PI LUSTER, ANDREW · 2014 to 2018
$9.8M
Innate control of the inflammatory process during fungal infectionsR01AI121066 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI ZANONI, IVAN · 2016 to 2025
$4.8M
Generation and Function of NK Cell MemoryR01AI111595 · NIAID · HARVARD MEDICAL SCHOOL · PI VON ANDRIAN, ULRICH H · 2013 to 2017
$4.1M
NIAID NIH HHS P01 AI112521NIAID NIH HHS R01 AI111595NIAID NIH HHS R01 AI121066NIDDK NIH HHS P30 DK034854
6 · The paper itself

Abstract

Natural killer (NK) cells are critical players against tumors. The outcome of anti-tumor vaccination protocols depends on the efficiency of NK-cell activation, and efforts are constantly made to manipulate them for immunotherapeutic approaches. Thus, a better understanding of NK-cell activation dynamics is needed. NK-cell interactions with accessory cells and trafficking between secondary lymphoid organs and tumoral tissues remain poorly characterized. Here, we show that upon triggering innate immunity with lipopolysaccharide (LPS), NK cells are transiently activated, leave the lymph node, and infiltrate the tumor, delaying its growth. Interestingly, NK cells are not actively recruited at the draining lymph node early after LPS administration, but continue their regular homeostatic turnover. Therefore, NK cells resident in the lymph node at the time of LPS administration become activated and exert anti-tumor functions. NK-cell activation correlates with the establishment of prolonged interactions with dendritic cells (DCs) in lymph nodes, as observed by two-photon microscopy. Close DC and NK-cell contacts are essential for the localized delivery of DC-derived IL-18 to NK cells, a strict requirement in NK-cell activation.

Indexed as

AnimalsDendritic CellsDisease Models, AnimalKiller Cells, NaturalLipopolysaccharidesLymph NodesLymphocyte ActivationMiceNeoplasmsLipopolysaccharidesdendritic cellsimmunosurveillanceinnate immunitynatural killer cellstwo‐photon microscopy

Identifiers

PMID27406819
PMCPMC5009809
OpenAlexW2473097366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.